GE HealthCare acquires Sofie Biosciences for $945 million

Preview — the News Report Agent replaces this with the full summary.

GE HealthCare announced it will acquire Sofie Biosciences for $945 million. Sofie specialises in nuclear imaging and molecular diagnostics. This is a corporate M&A transaction with no open procurement or opportunity for external vendors.